An inspiring talk today by #iantannock at ASCO-AIOM clinical research course: so many critical points raised and new perspectives shared.

Grateful to attend this course!

AIOM

Seconda edizione dell’ASCO-AIOM International Clinical Research Course: come sempre grande partecipazione ed entusiasmo.
#ASCO #AIOM ASCO

So many intriguing sessions today at #ESMOSarcomaAndRareCancers24 day 2 and many friends to share these days with

#retroperitonealsarcoma #rarecancerawareness

ESMO - Eur. Oncology

#young oncologists are a key part of rare cancers family!
Thanks all for coming to our clinical case discussion!
Every happy face in this picture is a reward for us in #ESMOYOC
Btw. Don’t miss our Vesalius talk about work-life overload at 12.15
#ESMOSarcomaAndRareCancers24

A great kick-off today in Lugano for
#ESMOSarcomaAndRareCancers24 !

Super-honoured for having my clinical case selected for discussion in the very first young oncologist session, and a big thank to Roberta Sanfilippo and Paolo G Casali for their strong support.

ESMO - Eur. Oncology

Thanks to Frontiers - Oncology for publishing today our report of a very rare disease successfully managed with a well known drug.

Istituto Tumori Roberta Sanfilippo Sandro Pasquali Paolo G Casali

Our work is out on ⁦JAMA Network Open⁩ ❗️

Is NALIRIFOX better than FOLFIRINOX as 1st line for metastatic #pancsm ❓
❎similar OS and PFS,
⚠️different clinical and 💰 toxicity

“I suppose we all thought that one way or another” jamanetwork.com/journals/jaman…

Beyond first line in #NSCLC WT: a real pleasure to listen to Giuseppe Lo Russo talking about future perspectives in this tough and challenging topic at #AIOM23 AIOM

A beautiful pic of #INT at #AIOM23 and good luck to Mario Occhipinti for starting his new course in #aiomgiovani working group.
Bravo! 🎉

Eletto ieri il nuovo Direttivo Nazionale AIOM.
A guidare la società scientifica per i prossimi due anni saranno:
Francesco Perrone , Presidente Nazionale;
Massimo Di Maio, Presidente Eletto;
Nicola Silvestris, Segretario Nazionale;
rossanaberardi, Tesoriere.

#AIOM23

Great to be here once again in Rome for #AIOM Congress. Many celebrations today for 50th anniversary and a wonderful presentation from my colleague and friend Achille Bottiglieri

AIOM

Unique opportunity to present the TOMAS2 trial with trabectedin + olaparib vs trabectedin in adv STS at #ESMO23 !
No diff in all comers but nice data in HRd and uLMS. More to come from ongoing translational analyses.
A great collaboration from Italian Sarcoma Group
Sarcoma UniTo

What an impactful Presidential symposium at #ESMO23 . THREE NEJM articles already: selpercatinib in #RET NSCLC, selpercatinib in medullary thyroid, and amivantamab with chemo in #EGFR exon 20. Congrats to Prof. Caicun Zhou - two first-author NEJM papers in one day!

👏🏻

How can we improve #clinicaltrial design in rare cancers? Great talk today by Giacomo G Baldi in Rome, and ad interesting workshop with young oncologists. New ideas are on track!

Thanks #aiomgiovani !
AIOM

Honored to have attended such a great meeting with amazing speakers! Thanks to Giuseppe Lo Russo and to all the faculty for organizing this outstanding event
#lungcancer #letsbreaktheIce

Emerging issues and new hot topics in Oncology shared today in Naples.
And a big cheer to arsela prelaj for her great talk!
See you soon in Rome, thanks to AIOM and #aiomgiovani

🚀 Grande passo per l'oncologia italiana!
È stato inaugurato il laboratorio di intelligenza artificiale presso l'Istituto Tumori Milano.
Con la guida dell'oncologa e dottoranda in ingegneria biomedica arsela prelaj , questo team multidisciplinare lavorerà con il Politecnico di…

Low grade uterine Leiomyosarcoma does exist !
aacrjournals.org/clincancerres/…
Paolo Dei Tos
Paolo G Casali
Marisa R Nucci
Ray-Coquard Isabelle
Jon Trent, MD, PhD
Croce Sabrina
Clinical Cancer Research
ChiaraFabbroni
CTOS
ESGO
LeioMyoSarcoma

Find out more about the role of IO in NSCLC with novel driver alterations. 👉 Our latest pubblication just out in Clinical Lung Cancer

Marta Brambilla
Teresa Beninato

clinical-lung-cancer.com/article/S1525-…